Entry Screening to Delay Local Transmission of 2009 Pandemic Influenza A (H1N1)

Overview

Journal BMC Infect Dis

Publisher Biomed Central

Specialty Infectious Diseases

Date 2010 Apr 1

PMID 20353566

Citations 75

Authors

Benjamin J Cowling

Lincoln L H Lau

Peng Wu

Helen W C Wong

Vicky J Fang

Steven Riley

Hiroshi Nishiura

Affiliations

Soon will be listed here.

Abstract

Background: After the WHO issued the global alert for 2009 pandemic influenza A (H1N1), many national health agencies began to screen travelers on entry in airports, ports and border crossings to try to delay local transmission.

Methods: We reviewed entry screening policies adopted by different nations and ascertained dates of official report of the first laboratory-confirmed imported H1N1 case and the first laboratory-confirmed untraceable or 'local' H1N1 case.

Results: Implementation of entry screening policies was associated with on average additional 7-12 day delays in local transmission compared to nations that did not implement entry screening, with lower bounds of 95% confidence intervals consistent with no additional delays and upper bounds extending to 20-30 day additional delays.

Conclusions: Entry screening may lead to short-term delays in local transmission of a novel strain of influenza virus. The resources required for implementation should be balanced against the expected benefits of entry screening.

Citing Articles

Infectious disease surveillance needs for the United States: lessons from Covid-19.

Lipsitch M, Bassett M, Brownstein J, Elliott P, Eyre D, Grabowski M Front Public Health. 2024; 12:1408193.

PMID: 39076420 PMC: 11285106. DOI: 10.3389/fpubh.2024.1408193.

Concealing Disease: Trade and Travel Barriers and the Timeliness of Outbreak Reporting.

Worsnop C Int Stud Perspect. 2024; 20(4):344-372.

PMID: 38626279 PMC: 7149472. DOI: 10.1093/isp/ekz005.

Domestic politics and the WHO's International Health Regulations: Explaining the use of trade and travel barriers during disease outbreaks.

Worsnop C Rev Int Organ. 2024; 12(3):365-395.

PMID: 38624276 PMC: 7149042. DOI: 10.1007/s11558-016-9260-1.

The economic impact of international travel measures used during the COVID-19 pandemic: a scoping review.

Bazak Y, Sander B, Werker E, Zhumatova S, Worsnop C, Lee K BMJ Glob Health. 2024; 9(2).

PMID: 38413100 PMC: 10900439. DOI: 10.1136/bmjgh-2023-013900.

Systematic Genomic Surveillance of SARS-CoV-2 at Xiamen International Airport and the Port of Xiamen Reveals the Importance of Incoming Travelers in Lineage Diversity.

You R, Wu R, Wang X, Fu R, Xia N, Chen Y Viruses. 2024; 16(1).

PMID: 38257832 PMC: 10821529. DOI: 10.3390/v16010132.

References

Wu J, Cowling B, Lau E, Ip D, Ho L, Tsang T . School closure and mitigation of pandemic (H1N1) 2009, Hong Kong. Emerg Infect Dis. 2010; 16(3):538-41. PMC: 3206396. DOI: 10.3201/eid1603.091216. View

Malone J, Brigantic R, Muller G, Gadgil A, Delp W, McMahon B . U.S. airport entry screening in response to pandemic influenza: modeling and analysis. Travel Med Infect Dis. 2009; 7(4):181-91. PMC: 7185379. DOI: 10.1016/j.tmaid.2009.02.006. View

Duncan A, Priest P, Jennings L, Brunton C, Baker M . Screening for influenza infection in international airline travelers. Am J Public Health. 2009; 99 Suppl 2:S360-2. PMC: 4504388. DOI: 10.2105/AJPH.2008.158071. View

Epstein J, Goedecke D, Yu F, Morris R, Wagener D, Bobashev G . Controlling pandemic flu: the value of international air travel restrictions. PLoS One. 2007; 2(5):e401. PMC: 1855004. DOI: 10.1371/journal.pone.0000401. View

Bell D, Nicoll A, Fukuda K, Horby P, Monto A, Hayden F . Non-pharmaceutical interventions for pandemic influenza, international measures. Emerg Infect Dis. 2006; 12(1):81-7. PMC: 3291414. DOI: 10.3201/eid1201.051370. View

Caley P, Becker N, Philp D . The waiting time for inter-country spread of pandemic influenza. PLoS One. 2007; 2(1):e143. PMC: 1764036. DOI: 10.1371/journal.pone.0000143. View

Cooper B, Pitman R, Edmunds W, Gay N . Delaying the international spread of pandemic influenza. PLoS Med. 2006; 3(6):e212. PMC: 1450020. DOI: 10.1371/journal.pmed.0030212. View

Wu J, Leung G, Lipsitch M, Cooper B, Riley S . Hedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapy. PLoS Med. 2009; 6(5):e1000085. PMC: 2680070. DOI: 10.1371/journal.pmed.1000085. View

Pitman R, Cooper B, Trotter C, Gay N, Edmunds W . Entry screening for severe acute respiratory syndrome (SARS) or influenza: policy evaluation. BMJ. 2005; 331(7527):1242-3. PMC: 1289362. DOI: 10.1136/bmj.38573.696100.3A. View

10.

Cauchemez S, Valleron A, Boelle P, Flahault A, Ferguson N . Estimating the impact of school closure on influenza transmission from Sentinel data. Nature. 2008; 452(7188):750-4. DOI: 10.1038/nature06732. View

11.

Mukherjee P, Lim P, Chow A, Barkham T, Seow E, Win M . Epidemiology of travel-associated pandemic (H1N1) 2009 infection in 116 patients, Singapore. Emerg Infect Dis. 2009; 16(1):21-6. PMC: 2874386. DOI: 10.3201/eid1601.091376. View

12.

. New influenza A (H1N1) virus: WHO guidance on public health measures, 11 June 2009. Wkly Epidemiol Rec. 2009; 84(26):261-4. View

13.

Khan K, Arino J, Hu W, Raposo P, Sears J, Calderon F . Spread of a novel influenza A (H1N1) virus via global airline transportation. N Engl J Med. 2009; 361(2):212-4. DOI: 10.1056/NEJMc0904559. View

14.

Lessler J, Reich N, Brookmeyer R, Perl T, Nelson K, Cummings D . Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis. 2009; 9(5):291-300. PMC: 4327893. DOI: 10.1016/S1473-3099(09)70069-6. View